A detailed history of Camber Capital Management LP transactions in Zimmer Biomet Holdings, Inc. stock. As of the latest transaction made, Camber Capital Management LP holds 2,500,000 shares of ZBH stock, worth $267 Million. This represents 8.57% of its overall portfolio holdings.

Number of Shares
2,500,000
Previous 1,925,000 29.87%
Holding current value
$267 Million
Previous $209 Million 29.18%
% of portfolio
8.57%
Previous 5.78%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$104.47 - $116.17 $60.1 Million - $66.8 Million
575,000 Added 29.87%
2,500,000 $270 Million
Q4 2023

Feb 14, 2024

BUY
$102.72 - $121.7 $7.7 Million - $9.13 Million
75,000 Added 4.05%
1,925,000 $234 Million
Q3 2023

Nov 14, 2023

BUY
$110.76 - $143.18 $88.6 Million - $115 Million
800,000 Added 76.19%
1,850,000 $208 Million
Q2 2023

Aug 14, 2023

SELL
$126.43 - $145.6 $25.3 Million - $29.1 Million
-200,000 Reduced 16.0%
1,050,000 $153 Million
Q4 2022

Feb 14, 2023

SELL
$104.7 - $128.4 $15.7 Million - $19.3 Million
-150,000 Reduced 10.71%
1,250,000 $159 Million
Q3 2022

Nov 14, 2022

BUY
$101.65 - $119.27 $5.08 Million - $5.96 Million
50,000 Added 3.7%
1,400,000 $146 Million
Q1 2022

May 16, 2022

BUY
$108.42 - $129.58 $37.9 Million - $45.4 Million
350,000 Added 35.0%
1,350,000 $173 Million
Q4 2021

Feb 14, 2022

BUY
$115.43 - $146.63 $31.7 Million - $40.3 Million
274,910 Added 37.91%
1,000,000 $127 Million
Q3 2021

Nov 15, 2021

BUY
$136.35 - $158.76 $98.9 Million - $115 Million
725,090 New
725,090 $106 Million
Q2 2021

Aug 16, 2021

SELL
$152.95 - $173.41 $95.6 Million - $108 Million
-625,000 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$148.16 - $159.71 $92.6 Million - $99.8 Million
625,000 New
625,000 $100 Million

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $22.4B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track Camber Capital Management LP Portfolio

Follow Camber Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Camber Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Camber Capital Management LP with notifications on news.